
Bone Grafts and Substitutes Market Report 2026
Global Outlook – By Material (Allograft, Synthetic, Xenograft), By Application (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, Dental Bone Grafting, Other Applications), By End User (Hospitals And Clinics, Surgical Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Bone Grafts and Substitutes Market Overview
• Bone Grafts and Substitutes market size has reached to $3.57 billion in 2025 • Expected to grow to $4.72 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Rising Musculoskeletal Disorders Drive Demand For Bone Grafts And Substitutes • Market Trend: New Product Innovations Drive Growth In Bone Grafts And Substitutes Market • North America was the largest region in 2025.What Is Covered Under Bone Grafts and Substitutes Market?
Bone grafts and substitutes refer to a procedure in which bone defects are filled with bone grafts or with bone graft substitutes. Bone abnormalities that necessitate bone grafting are common in trauma and orthopedic operations. Bone grafting can be described as the envelopment and interdigitation of the donor bone tissue with the new bone deposited by the recipient. It is versatile, replaces the lost bone tissue, and enhances bone growth using natural mechanisms. The bone grafts and substitutes are used to replace and regenerate the lost bone, and can also restore proper facial contour. The main types of bone grafts and substitutes are allografts, synthetics, and xenografts. Allograft bone grafts and substitutes refer to a tissue graft from a donor of the same species as the recipient. Allografts are commonly used in spinal fusion surgery. The various applications include spinal fusion, trauma, craniomaxillofacial, joint reconstruction, dental bone grafting, and others, which are used by several end users such as hospitals, surgical centers, and others.
What Is The Bone Grafts and Substitutes Market Size and Share 2026?
The bone grafts and substitutes market size has grown strongly in recent years. It will grow from $3.57 billion in 2025 to $3.79 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising incidence of orthopedic trauma cases, expansion of spinal fusion surgeries, growing adoption of dental bone grafting, availability of allograft materials, increased orthopedic surgical volumes.What Is The Bone Grafts and Substitutes Market Growth Forecast?
The bone grafts and substitutes market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for advanced bone regeneration solutions, rising adoption of synthetic graft substitutes, expansion of minimally invasive orthopedic surgeries, growing focus on personalized regenerative medicine, increasing investments in biomaterial research. Major trends in the forecast period include increasing adoption of synthetic and composite bone grafts, rising use of bioactive and osteoinductive materials, growing integration of advanced biomaterials in orthopedics, expansion of minimally invasive bone repair procedures, enhanced focus on bone regeneration outcomes.Global Bone Grafts and Substitutes Market Segmentation
1) By Material: Allograft, Synthetic, Xenograft 2) By Application: Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, Dental Bone Grafting, Other Applications 3) By End User: Hospitals And Clinics, Surgical Centers, Other End-Users Subsegments: 1) By Allograft: Demineralized Bone Matrix (DBM), Fresh Frozen Allografts, Freeze-Dried Allografts 2) By Synthetic: Ceramic-Based, Polymer-Based, Composite-Based 3) By Xenograft: Bovine-Derived Grafts, Porcine-Derived GraftsWhat Is The Driver Of The Bone Grafts and Substitutes Market?
The rise in the incidence of musculoskeletal disorders such as osteoporosis and tendonitis is expected to propel the growth of the bone grafts and substitutes market going forward. Musculoskeletal disorders are types of injuries and disorders that affect the human body's movement and musculoskeletal system. These cause disorders in muscles, nerves, tendons, joints, cartilage, and spinal discs. As a result, there is an increase in musculoskeletal disorders, an increase in demand for bone grafts, and the substitutes market. For instance, in July 2025, according to the Institute for Health Transformation, an Australia-based organization dedicated to addressing complex and compelling health challenges through collaborative research, posted that by 2033, 7.7 million Australians aged 50 years and older are predicted to have osteoporosis and osteopenia, an increase of 23% from 2023. Therefore, the increasing growth of the incidence of musculoskeletal disorders helps to increase the demand for the bone grafts and substitutes industry.Key Players In The Global Bone Grafts and Substitutes Market
Major companies operating in the bone grafts and substitutes market are Medtronic plc, Stryker Corporation, Smith & Nephew, Johnson & Johnson, Zimmer Biomet, SeaSpine, Integra Lifesciences Holdings Corporation, NuVasive Inc., Orthofix Holdings Inc., Straumann, Geistlich Bio-Oss, Exabone GmbH, Mathys AG, Dentsply Sirona Inc, Arthrex Inc, Graftys, Keystone Dental, Allosource, DePuy Synthes, Wright Medical Group N.V.Global Bone Grafts and Substitutes Market Trends and Insights
Major companies operating in the bone grafts and substitutes market are focusing on developing innovative solutions, such as antibiotic-eluting bone graft substitutes, to meet the rising demand for advanced, infection-resistant grafting materials. Antibiotic-eluting bone graft substitutes are biomaterials designed to fill bone defects while simultaneously releasing antibiotics to prevent postoperative infections, offering improved outcomes compared to traditional grafts. For instance, in June 2023, BONESUPPORT, a Sweden-based medical technology company, launched CERAMENT G, an innovative antibiotic-eluting bone graft substitute. The product features a refined kit that is 28% smaller, incorporates surface-sterile components for simplified handling, offers enhanced usability, and provides a longer three-year shelf life. It maintains the same composition and mechanism of action as earlier versions while improving environmental sustainability and surgical workflow efficiency.What Are Latest Mergers And Acquisitions In The Bone Grafts and Substitutes Market?
In June 2023, Biocomposites, a UK-based medical technology company, acquired Artoss GmbH for an undisclosed amount. Through this acquisition, Biocomposites aims to strengthen its portfolio by integrating Artoss’ innovative NanoBone technology and research capabilities, thereby enhancing its offerings in bone graft substitutes for orthopedic, spine, foot and ankle, and dental applications, and expanding its presence in the global bone graft market. Artoss GmbH is a Germany-based biotechnology company that specializes in developing and manufacturing advanced bone graft substitute products.Regional Outlook
North America was the largest region in the bone grafts and substitutes market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Bone Grafts and Substitutes Market?
The bone grafts and substitutes market consists of sales of xenograft tissue, alloplast bone graft, autograft tissue, and allograft tissue. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Bone Grafts and Substitutes Market Report 2026?
The bone grafts and substitutes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bone grafts and substitutes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Bone Grafts and Substitutes Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.79 billion |
| Revenue Forecast In 2035 | $4.72 billion |
| Growth Rate | CAGR of 6.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Material, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Medtronic plc, Stryker Corporation, Smith & Nephew, Johnson & Johnson, Zimmer Biomet, SeaSpine, Integra Lifesciences Holdings Corporation, NuVasive Inc., Orthofix Holdings Inc., Straumann, Geistlich Bio-Oss, Exabone GmbH, Mathys AG, Dentsply Sirona Inc, Arthrex Inc, Graftys, Keystone Dental, Allosource, DePuy Synthes, Wright Medical Group N.V. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
